-
Product Insights
Refractory Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Refractory Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Refractory Medulloblastoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Refractory Medulloblastoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history...
-
Sector Analysis
Hodgkin Lymphoma - Epidemiology Forecast to 2029
HL is a cancerous condition that affects the lymphatic system and occurs in both children and adults. HL is a rare disease that starts with abnormal growth of the white blood cells, called lymphocytes, and then spreads beyond the lymphatic system and impairs the body’s immune system. HL is classified into two main groups—cHL and NLPHL. cHL is further divided into subtypes, namely nodular sclerosis, mixed cellularity, lymphocyte-rich, and lymphocyte-depleted. The classical form is the most frequently occurring HL, with...
-
Product Insights
Laryngeal Cancer Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Laryngeal Cancer Global Clinical Trials Review, H1, 2020" provides an overview of Laryngeal Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Laryngeal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Neuroendocrine Tumors Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Neuroendocrine Tumors Global Clinical Trials Review, H1, 2020" provides an overview of Neuroendocrine Tumors Clinical trials scenario. This report provides top line data relating to the clinical trials on Neuroendocrine Tumors. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Global Clinical Trials Review, H1, 2020" provides an overview of Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Clinical trials scenario. This report provides top line data relating to the clinical trials on Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease...
-
Sector Analysis
Bladder Cancer - Epidemiology Forecast to 2028
Bladder cancer is a common cancer worldwide that occurs when there is uncontrolled cell growth in the bladder lining, most commonly in urothelial cells. The most common risk factor of bladder cancer is tobacco use and cigarette smoking. The risk of bladder cancer also increases with older age, with people ages 65 years and older accounting for 70% of cases. Men are also four times more likely to develop bladder cancer compared with women. Bladder cancer types include carcinoma in...
-
Product Insights
Endometrial Cancer Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H1, 2020" provides an overview of Endometrial Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Endometrial Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Bile Duct Cancer (Cholangiocarcinoma) Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2020" provides an overview of Bile Duct Cancer (Cholangiocarcinoma) Clinical trials scenario. This report provides top line data relating to the clinical trials on Bile Duct Cancer (Cholangiocarcinoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
B-Cell Non-Hodgkin Lymphoma Disease - Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2020" provides an overview of B-Cell Non-Hodgkin Lymphoma Clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cell Non-Hodgkin Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.